Urocanic acid
Names | |
---|---|
Preferred IUPAC name
(2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid | |
Other names
(E)-3-(1H-imidazol-4-yl)acrylic acid
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChemSpider | |
ECHA InfoCard
|
100.002.963 |
MeSH | Urocanic+acid |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H6N2O2 | |
Molar mass | 138.124 g/mol |
Melting point | 225 °C (437 °F; 498 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Urocanic acid (formally trans-Urocanic acid) is an intermediate in the
Metabolism
It is formed from L-histidine through the action of
In the liver, urocanic acid is transformed by
Clinical significance
Inherited deficiency of urocanase leads to elevated levels of urocanic acid in the urine, a condition known as urocanic aciduria.
An important role for the onset of atopic dermatitis and asthma has been attributed to filaggrin, a skin precursor of urocanic acid.[1][2]
Urocanic acid is thought to be a significant attractant of the nematode parasite Strongyloides stercoralis,[3] in part because of relatively high levels in the plantar surfaces of the feet, the site through which this parasite often enters the body.
Function
Urocanic acid was detected in animal sweat and skin where, among other possible functions, it acts as an endogenous sunscreen or photoprotectant against
Some studies attribute filaggrin an important role in keeping the skin surface slightly acidic, through a breaking down mechanism to form histidine and subsequently trans-urocanic acid,[6] however others have shown that the filaggrin–histidine–urocanic acid cascade is not essential for skin acidification.[7]
History
Urocanic acid was first isolated in 1874 by the chemist
See also
- Histidinemia
- Inborn error of metabolism
References
External links
- The Online Metabolic and Molecular Bases of Inherited Disease - Chapter 80 - An overview of disorders of histidine metabolism, including urocanic aciduria.